Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD

Eur Respir J. 2016 Feb;47(2):651-4. doi: 10.1183/13993003.01644-2015. Epub 2015 Nov 19.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / therapeutic use*
  • Adrenergic beta-2 Receptor Agonists / therapeutic use*
  • Drug Therapy, Combination
  • Fluticasone / therapeutic use
  • Forced Expiratory Volume
  • Humans
  • Muscarinic Antagonists / therapeutic use*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Salmeterol Xinafoate / therapeutic use
  • Severity of Illness Index
  • Tiotropium Bromide / therapeutic use
  • Withholding Treatment

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-2 Receptor Agonists
  • Muscarinic Antagonists
  • Salmeterol Xinafoate
  • Fluticasone
  • Tiotropium Bromide